Literature DB >> 2936660

Incorporation of intermediary products of 5-FU anabolism into colorectal cancer.

G R Giles, L Woodhouse, P J Finan, E M Chisholm.   

Abstract

In 18 patients intermediary anabolic metabolites of 5-FU were measured in normal colonic mucosa and colorectal cancer tissue of intravenous bolus injection or continuous infusion. Higher total concentrations of 5-FU products were found in the cancers when compared with normal colonic tissue. There appeared to be no evidence, however, that some patients had a selectively increased ability to incorporate 5-FU into their tumours. Overall higher concentrations of tumour incorporation of 5-FU were found after bolus injection rather than the infusion method, although this difference is statistically not significant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2936660      PMCID: PMC1433191          DOI: 10.1136/gut.27.2.176

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Further clinical studies with 5-fluorouracil.

Authors:  F J ANSFIELD; A R CURRERI
Journal:  J Natl Cancer Inst       Date:  1959-03       Impact factor: 13.506

2.  Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil.

Authors:  B Ardalan; D A Cooney; H N Jayaram; C K Carrico; R I Glazer; J Macdonald; P S Schein
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

Review 3.  Fluorinated pyrimidines.

Authors:  C Heidelberger
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1965

4.  The synthesis of 5-fluorouridine 5'-phosphate by a pyrimidine phosphoribosyltransferase of mammalian origin. I. Some properties of the enzyme from P1534J mouse leukemic cells.

Authors:  P Reyes
Journal:  Biochemistry       Date:  1969-05       Impact factor: 3.162

5.  Thymidylate synthetase: mechanism of inhibition by 5-fluoro-2'-deoxyuridylate.

Authors:  R J Langenbach; P V Danenberg; C Heidelberger
Journal:  Biochem Biophys Res Commun       Date:  1972-09-26       Impact factor: 3.575

6.  Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver.

Authors:  C K Carrico; R I Glazer
Journal:  Cancer Res       Date:  1979-09       Impact factor: 12.701

7.  Modified nucleosides in urine: selective removal and analysis.

Authors:  M Uziel; L H Smith; S A Taylor
Journal:  Clin Chem       Date:  1976-09       Impact factor: 8.327

8.  Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.

Authors:  P Seifert; L H Baker; M L Reed; V K Vaitkevicius
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

9.  Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration.

Authors:  N Chirstophidis; F J Vajda; I Lucas; O Drummer; W J Moon; W J Louis
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

10.  Preliminary studies of the uridine kinase activity of human colorectal adenocarcinomas.

Authors:  N K Ahmed; R C Haggitt; A D Welch
Journal:  Cancer       Date:  1981-09-01       Impact factor: 6.860

View more
  1 in total

1.  Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model.

Authors:  A D Flowerdew; H K Richards; I Taylor
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.